hotcopper spl. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. hotcopper spl

 
Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022hotcopper spl  Created with Sketch

SPL Price at posting: 49. LEADING THE BATTERY METALS REVOLUTION. I sold out of my position in SPL at that time precisely because of this. It is easy to be a negative poster on here when there has not been anything positive to come out of the company for a looooong time. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. Provide some keywords to assist in categorisation of your abstract. HotCopper is Australia's largest free and independent stock market trading forum for. ASX - By Stock. 15. Virtual investor presentation Tomorrow night Starpharma will be Participating in a virtual investorpresentation on the OTC website for those that are. Forums. ASX - General. ASX - By Stock. Forums. Hey, "smart", I concur with your message. Hey, "smart", I concur with your message. The matter has been adjourned to. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. Latest Posts. 0000. 50 At this stage in the game, I would not accept anything under $5 (fact)Btw if Starpharma do receive an upfront milestone of $300 million for Dep Docetaxel, Dep Cabazitaxel and Dep Irinotecan license, I believe a special dividend will be paid out to all. ASX - By Stock. . Market . Join the HotCopper ASX share. Since then. The sycophants, pompom-wavers, management apologists, cheerleaders and perennial uprampers of SPL on a Hotcopper know who they are. 0¢ Sentiment: None Disclosure: Held LikesThe CEO seemed to exude a certain excitement in her interview with Alan Kholher have never seen her like that it was bubbling underneath every time she spoke about Viralease. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - By Stock. SPL. Target our investor community with our suite of Hotcopper Advertising opportunities. Comments. ASX - Short Term Trading. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". ASX - Day TradingSPL buy back distribution agreement , LLoyds hand it back or SPL formally takes action for the agreement to be cancelled due to a default in obligations. StarPharma Holdings Ltd. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. Enter the title of your abstract. 0834. Latest Posts. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. . Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. Starpharma AGM Summary (Part 1) Oh. The digital display offers a 0. 00%. With SPL we have entered a relatively short term period where things are going to develop into something serious. . Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. Its time SPL got down and dirty and prepare their WAR plan in anticipation of the trial being successful. Click for more information. ASX - Day Trading SUBMISSION STEPS. I visited their offices in Melbourne near the Alfred a few times and thought they were on to some pretty neat tech. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. 37 Sentiment: Buy Disclosure: Held. The thread is titled so that it can be found and general enough so as to. The goal of the partnership. SPL always has tantalising carrots to dangle before the eyes of investors. Canadian Dollar. I averaged down over the next year and the lowest point I bought was at 57c. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. 28pm 13/11/2023 ? TMG (ASX) Chart. Target our investor community with our suite of Hotcopper. Latest Posts. I hope I'm wrong here. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. ASX - Short Term Trading. . Created with Sketch. . 0012. SPL is tanking, HQ are overpromising and under delivering. As always, she is happy to hoover up freebie shares in the grandiose remuneration agreements as well as collect performance bonuses as disclosed in the Annual Report. . granted mgt haven’t covered themselves in glory as yet but the selldown has been nothing short of astonishing. 36. great news but unlikely. . . I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Time to put your feet up and kick back for a while. Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. 72. StarPharma Holdings Ltd. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. 57% 13. 8¢. 40. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . Join the HotCopper ASX share market forum today for free. 0¢. 56am 20/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. 63. 36. ASX - By Stock. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. It is, to me, incredibly frustrating that SPL releases a good report with great promise and income mentions yet the market response is LIMP with a rise of. $0. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. ASX - Day Trading. A halleluljah announcement just days before the AGM would imo be proof that investors in SPL have for years been treated like mugs. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. Hey, "smart", I concur with your message. Forums. Last updated 14. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . But I’ve been having a. ASX - General. Join the HotCopper ASX share market. Market . 83453. Each to their own. To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. ASX - By Stock. Forums. 74. 58. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. Prior to the trial results being released SPL need to get on the front foot. Volume. SPL need to show and reassure them that AZD0466 was cancelled not because of the dendrimer technology. m. Ena Respiratory is getting news coverage everywhere - newspapers, onilne, 7 morning news, more coverage than I've seen for SPL - “By boosting the natural immune response of the ferrets with our treatment, we’ve seen a rapid eradication of the virus,” he explained in a statement. 409118. Name/company Polymer Drug, class/loading method Delivery system type/size Clinical stage/indication; CPC634. Created with Sketch. Surely, surely these great technical achievements will translate into commercial gains for the company and us long suffering SPL Shareholders. . 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. July 31 (Reuters) - Starpharma Holdings Ltd (SPL) : ASTRAZENECA HAS MADE DECISION TO DISCONTINUE DEVELOPMENT OF AZD0466, AFTER AN INTERNAL REVIEW. I saw that some director etc invested there own money in the SPP etc,. 5¢. 70. 362771. 1 Upvote. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. $1. This product was expected to produce rivers of. SPL Price at posting: 44. 0 Created with. . ASX - By Stock. In summary, my observations about SPL are: Marketing - persistent. Click for. by other companies i meant those associated with SPL, and ask what up from their end. They need IMO to define good and any other qualifying words !!. ASX - By Stock. Starpharma was 96 cents in April 2002. Market Cap $55. Target our investor community with our. . Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. . Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. Share I sometimes wonder if they actually work at Starpharma. ASX - Day TradingAnyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 2:00 am Eastern Standard Time Australia. Target our investor community with our. Click for more information. Zeus Resources Limited is an Australia-based mineral exploration company. . Even Pfizer won’t comment on him. Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. Last updated 15. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. 1029/9/2000 SPL $0. $0. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. Investors and the ASX now have their eye on SPL like they normally would have on dodgy mining penny stocks. . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Forums. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. FORTESCUE METALS GROUP LTD. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 0. - 12:30 p. Disowned him really. Join the HotCopper ASX share market forum today for free. It looks like SPL will need a BLOCKBUSTER ANNOUNCEMENT with $$$$$ attached plus a SATURN ROCKET up its clacker to take off. Created with Sketch. 50 peak) that they hadn’t missed the boat and that SPL was soon going to $3. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. Forums. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Hey, "smart", I concur with your message. 17112. $0. All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP. Market . IMO they haven't . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. ASX - By Stock. Join the HotCopper ASX share market forum today for free. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. Market . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). SPL Price at posting: 14. Only 12 episodes made but so Iconic . . If only we had the viraleze. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. Contacts. Latest Posts. ROFL. Join the HotCopper ASX share market forum today for free. Latest Posts. Created with Sketch. They are the future as also mentioned regularly by Eric Topol. SPL Price at posting: 71. Share It would be silly to be tight on cash. 0. The Vancouver Island Wave program is the Island’s highest level of youth soccer participating in the BC Soccer Premier League. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. Join the HotCopper ASX share market forum today for free. . Created with Sketch. ASX - By Stock. 0¢. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. 6% (1. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. Created with Sketch. A sad state of affairs IMO. . . MarketDep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. 56. 63M. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. . ASX - General. 00%. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Created with Sketch. 0. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Created with Sketch. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. , Inc. Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. Created with Sketch. . Created with Sketch. 48. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. 199920. 8985. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. . Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable. bc. . The rules obviously do not apply in Starpharma Land with CEO Jackie Fairley. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. It is a real eye opener and paints the Pharmaceutical Industry in a very bad light. 0. are either confused or talking nonsense. Target our investor community with our suite of Hotcopper Advertising opportunities. The recent announcement about Viraleze nasal. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. . Target our investor community with our suite of Hotcopper Advertising. Created with Sketch. Since then. Market . Maybe SPL is frustrated at the lack of promotion, or maybe they have frustrated McKesson with continuity of supply, but I doubt it this early in the relationship - the logistics will be guided by demand, and it takes time to find the right equilibrium without overcommitting funds and/or scaling up manufacturing capacity, honouring contracts etc. 1. In SPL's case there is clearly another. ASX - By Stock. . Twenty years later it’s 84. Advertise on HotCopper. , page-2. Join the HotCopper ASX share market forum today for free. Dr. Market Cap $58. Last updated 15. There appears to be a different behavioural feel about. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. LEADING THE BATTERY METALS REVOLUTION. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. . Latest Posts. Forums. GLTAH but for me SPL is still a strong AVOID until a development of substance is announced. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. So SPL have written responses to shareholders saying Viraleze is avaliable under existing exclusive deal with LLoyds but for some unknown reason SPL have developed a " dedicated VIRALEZE™ product UK webstore" and "other online channels" conveniently at a time when LLoyds seem to have destocked stores and webstore no. It is lengthy but well worth the time. 8. Hey, "smart", I concur with your message. Your statement below masquerading as a fact could mislead less experienced investors on this Hotcopper forum. Last updated 15. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. Created with Sketch. Charts. The thread is titled so that it can be found and general enough so as to. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. 0¢. Market . If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. Created with Sketch. Share In the last year we have seen the resignation of the Head of Research, David Owen and now the Chief Financial Officer, Nigel Baade. yet if one considers that the amount of millions of shares via option they. Created with Sketch. My understanding is this condition has not been met however each KMP has received 191,152 rights for this alongside other staff whose allocation will no doubt vary according to the capacity of their employment. Created with Sketch. ASX - Short Term Trading. Become a member of Australia's largest investment discussion forum. 5¢. ASX - Short Term Trading. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. and even when Big pharma are challenged legally and lose in court as in Johnson and Johnson bladder slings - its 20 years after the tort, 8 yrs fighting in court to then be waiting waiting waiting for compensation not for pain and suffering in VICTORIA just inconvenience costs such as buying pads and pain killers. 0¢ STARPHARMA HOLDINGS LIMITED - Discussion. 0¢. Unusual to make that announcement?. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Charts. , page-2. The main difference between shareholders and the board and their illustrious leader seems to be just in use of English language, small discrepancies like "well advanced" might me to you or I an agreement is pending, can be expected shortly, what it means to Jackie it would seem is she has undertaken a google search to see who might sell a product such as Viraleze in an particular country. 0¢. 607432. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. 45K. Join the HotCopper ASX share market forum today for free. ASX - General. Enter the title of your abstract. Share New future tech coming Antibody fragment-nanoparticle therapeutic eradicates cancerPosted YesterdayA multi-institutional team of researchers found novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicating gastric cancer in treated mice. 0¢. We would like to show you a description here but the site won’t allow us. SPL. It seems long-suffering retail. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. Charts. ASX - By Stock. So SPL did the one thing they could to challenge the TGA they sent it to adjudication and TGA were told Feb 22 - you must accept application as medical device and SPL announced to ASX in April 22 that their application was in. ” ~@sarge17 Last edited by sarge17 : 24/02/23 SPL Price at posting: 54. Forex. Latest Posts. Join the HotCopper ASX share market forum today for free. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. The purpose of many of us working in pharmaceutical research and development whether within the industry or academia is to deliver medicines to improve the lives of patients around the world. ASX - By Stock. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. Share So I am guessing nothing came from the Merck meeting Jackie given they were promoted by name in the Shareholder Update on 3 June as a big meeting to be held on the USA holiday ASCO trip and they have been a 'partner' (and I use that term lightly with this mob) for 10 months longer than Genentech so Merck's research should be much further advanced IMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. For a small cap like spl where the revenue stream created would be very large in the context of our current. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. One of those is worse that SPL. . I am not up to date with all brexit stuff let alone othe rcountries like Vietnam , HK and very cautiious about consultants websites and simply govt websites area nightmare to understand and navigate unless it is your speciality. 13. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. Latest Posts. ASX - General. 5. I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. Created with Sketch.